Wibke E. Diederich

2.0k total citations
55 papers, 1.6k citations indexed

About

Wibke E. Diederich is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Wibke E. Diederich has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 14 papers in Organic Chemistry and 11 papers in Infectious Diseases. Recurrent topics in Wibke E. Diederich's work include Computational Drug Discovery Methods (11 papers), HIV/AIDS drug development and treatment (10 papers) and Chemical Synthesis and Analysis (10 papers). Wibke E. Diederich is often cited by papers focused on Computational Drug Discovery Methods (11 papers), HIV/AIDS drug development and treatment (10 papers) and Chemical Synthesis and Analysis (10 papers). Wibke E. Diederich collaborates with scholars based in Germany, United States and India. Wibke E. Diederich's co-authors include G. Klebe, Michael Daude, Robert Grosse, Carsten Culmsee, Andreas Blum, Anja Jelinek, Matthias Plessner, H. Steuber, A. Heine and Rolf Müller and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Journal of Molecular Biology.

In The Last Decade

Wibke E. Diederich

53 papers receiving 1.5k citations

Peers

Wibke E. Diederich
Ganesha Rai United States
Yew Mun Lee Singapore
Benito Muñoz United States
Jon Read United Kingdom
Tove Tuntland United States
Amit V. Pandey Switzerland
Ganesha Rai United States
Wibke E. Diederich
Citations per year, relative to Wibke E. Diederich Wibke E. Diederich (= 1×) peers Ganesha Rai

Countries citing papers authored by Wibke E. Diederich

Since Specialization
Citations

This map shows the geographic impact of Wibke E. Diederich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wibke E. Diederich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wibke E. Diederich more than expected).

Fields of papers citing papers by Wibke E. Diederich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wibke E. Diederich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wibke E. Diederich. The network helps show where Wibke E. Diederich may publish in the future.

Co-authorship network of co-authors of Wibke E. Diederich

This figure shows the co-authorship network connecting the top 25 collaborators of Wibke E. Diederich. A scholar is included among the top collaborators of Wibke E. Diederich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wibke E. Diederich. Wibke E. Diederich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brichkina, Anna, Rajeev Singh, Veronika Lutz, et al.. (2024). DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. Gut. 73(10). 1684–1701. 8 indexed citations
2.
Brichkina, Anna, Florian Finkernagel, Alexander Visekruna, et al.. (2023). Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment. NAR Cancer. 5(1). zcad007–zcad007. 2 indexed citations
3.
Diederich, Wibke E., et al.. (2019). Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies. Journal of Medicinal Chemistry. 62(18). 8392–8411. 26 indexed citations
4.
Köllisch, Gabriele, Wibke E. Diederich, Andreas M. Kaufmann, et al.. (2019). The Bacterial Product Violacein Exerts an Immunostimulatory Effect Via TLR8. Scientific Reports. 9(1). 13661–13661. 31 indexed citations
5.
6.
Chevillard, Florent, Cecilia Betti, Els Pardon, et al.. (2018). Binding-Site Compatible Fragment Growing Applied to the Design of β2-Adrenergic Receptor Ligands. Journal of Medicinal Chemistry. 61(3). 1118–1129. 37 indexed citations
8.
Schiebel, J., Nedyalka Radeva, Helene Köster, et al.. (2015). One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists. ChemMedChem. 10(9). 1511–1521. 52 indexed citations
9.
Adhikary, Till, Annika Wortmann, Tim Schumann, et al.. (2015). The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state. Nucleic Acids Research. 43(10). 5033–5051. 66 indexed citations
10.
Köster, Helene, Ah Young Park, A. Heine, et al.. (2015). Tracing Binding Modes in Hit‐to‐Lead Optimization: Chameleon‐Like Poses of Aspartic Protease Inhibitors. Angewandte Chemie International Edition. 54(9). 2849–2853. 25 indexed citations
11.
Sousa, Lorena Ramos Freitas de, Hongmei Wu, Liliane Nebo, et al.. (2014). Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies. Bioorganic & Medicinal Chemistry. 23(3). 466–470. 123 indexed citations
12.
Adhikary, Till, Dominique T. Brandt, Kerstin Kaddatz, et al.. (2012). Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion. Oncogene. 32(44). 5241–5252. 75 indexed citations
13.
Pape, Veronika F.S., et al.. (2011). Development of Improved PPARβ/δ Inhibitors. ChemMedChem. 7(1). 159–170. 26 indexed citations
14.
Adhikary, Till, Kerstin Kaddatz, Veronika F.S. Pape, et al.. (2011). High-Affinity Peroxisome Proliferator-Activated Receptor β/δ-Specific Ligands with Pure Antagonistic or Inverse Agonistic Properties. Molecular Pharmacology. 80(5). 828–838. 35 indexed citations
15.
Blum, Andreas, et al.. (2011). Two Solutions for the Same Problem: Multiple Binding Modes of Pyrrolidine-Based HIV-1 Protease Inhibitors. Journal of Molecular Biology. 410(4). 745–755. 8 indexed citations
16.
Steuber, H., Björn Over, Hans‐Dieter Gerber, et al.. (2010). Fragment‐Based Lead Discovery: Screening and Optimizing Fragments for Thermolysin Inhibition. ChemMedChem. 5(6). 930–940. 24 indexed citations
17.
Diederich, Wibke E., et al.. (2010). Stability-indicating HPLC assays for the determination of piritramide and droperidol in PCA solution. Journal of Clinical Pharmacy and Therapeutics. 36(2). 161–165. 7 indexed citations
19.
Böttcher, Jark, et al.. (2008). Targeting the Open‐Flap Conformation of HIV‐1 Protease with Pyrrolidine‐Based Inhibitors. ChemMedChem. 3(9). 1337–1344. 27 indexed citations
20.
Gerlach, Christof, Martin Münzel, Bernhard Baum, et al.. (2007). KNOBLE: A Knowledge‐Based Approach for the Design and Synthesis of Readily Accessible Small‐Molecule Chemical Probes To Test Protein Binding. Angewandte Chemie International Edition. 46(47). 9105–9109. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026